Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Black Friday
Enjoy this offer
* See conditions under "Our services"

Valuation: Guangzhou Kingmed Diagnostics Group Co., Ltd.

Capitalization 1.4TCr 196.71Cr 169.6Cr 156.48Cr 149.33Cr 275.95Cr 17TCr 302.48Cr 1.86TCr 717.42Cr 8.32TCr 737.72Cr 722.59Cr 31TCr P/E ratio 2025 *
425x
P/E ratio 2026 * 27x
Enterprise value 1.13TCr 158.9Cr 137Cr 126.41Cr 120.63Cr 222.91Cr 14TCr 244.34Cr 1.5TCr 579.53Cr 6.72TCr 595.93Cr 583.71Cr 25TCr EV / Sales 2025 *
1.84x
EV / Sales 2026 * 1.62x
Free-Float
53.05%
Yield 2025 *
0.2%
Yield 2026 * 1.33%
More valuation ratios * Estimated data
Dynamic Chart
29/10 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
22/08 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
09/07 Kingmed Diagnostics Shareholder to Trim Stake MT
28/05 GeneMind Biosciences Co., Ltd. announced that it has received CNY 280 million in funding from a group of investors CI
29/04 UOB Kay Hian Downgrades Guangzhou Kingmed Diagnostics Group to Hold from Buy; Price Target is 26 Yuan MT
25/04 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25/04 Kingmed Diagnostics' 2024 Net Loss At 381.2 Million Yuan RE
08/02 Declaration of Voting Results by Guangzhou Kingmed Diagnostics Group Co CI
24/01 Guangzhou Kingmed Diagnostics Group Co Receives a Proposal from Liang Yaoming CI
24/01 Kindstar Global Medical Technology Co., Ltd. acquired Guangzhou Kangcheng Weiye Biotechnology Co., Ltd.from Guangzhou Kingmed Diagnostics Group Co., Ltd., WuXi App Investment Ventures I, Suzhou Frontline BioVentures Venture Capital Fund II L.P., Suzhou 6Dimensions Venture Capital Partnership L.P., Suzhou Serica Jianxin Venture Capital Fund L.P. and AnchorDx Group HK Limited. CI
30/24/30 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
20/24/20 Kindstar Global Medical Technology Co., Ltd. agreed to acquire Guangzhou Kangcheng Weiye Biotechnology Co., Ltd.from Guangzhou Kingmed Diagnostics Group Co., Ltd., WuXi App Investment Ventures I, Suzhou Frontline BioVentures Venture Capital Fund II L.P., Suzhou 6Dimensions Venture Capital Partnership L.P., Suzhou Serica Jianxin Venture Capital Fund L.P. and AnchorDx Group HK Limited. CI
30/24/30 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
More news
1 day-1.02%
1 week+2.37%
Current month+0.94%
1 month+5.93%
3 months+0.07%
6 months-1.05%
Current year+9.63%
More quotes
1 week 29.65
Extreme 29.65
31.15
1 month 27.99
Extreme 27.99
31.15
Current year 24.35
Extreme 24.35
42
1 year 24.35
Extreme 24.35
42
3 years 24.35
Extreme 24.35
92.91
5 years 24.35
Extreme 24.35
178.88
10 years 9.98
Extreme 9.98
178.88
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2006
Director of Finance/CFO 55 26/06/2015
Corporate Officer/Principal 45 01/01/2021
Director TitleAgeSince
Chairman 61 01/01/2006
Director/Board Member 56 01/01/2006
Director/Board Member 59 01/01/2006
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.02%+2.37%-8.74%-59.68% 198.97Cr
+0.86%+3.24%+41.07%+460.96% 2.82TCr
-0.64%-1.21%-20.36%-36.13% 690.15Cr
+2.51%-1.62%-3.19%+366.06% 579.75Cr
+1.16%-7.29%+89.32%+426.95% 370.15Cr
-0.07%+2.16%+6.35%+31.16% 297.13Cr
+8.45%+0.51%+14.60%-3.28% 164.12Cr
-1.76%+0.31%+23.74%-43.16% 141.61Cr
-1.16%+1.39%-32.05%-8.09% 133.79Cr
-0.74%-7.29%+47.04%+30.17% 130.99Cr
Average +0.80%-2.21%+15.78%+116.50% 552.6Cr
Weighted average by Cap. +1.07%-1.42%+25.46%+296.51%
See all sector performances

Financials

2025 *2026 *
Net sales 612.98Cr 86Cr 74Cr 69Cr 65Cr 120.98Cr 7.64TCr 132.62Cr 815.84Cr 314.54Cr 3.65TCr 323.44Cr 316.81Cr 13TCr 709.27Cr 100Cr 86Cr 79Cr 76Cr 139.99Cr 8.84TCr 153.45Cr 944Cr 363.95Cr 4.22TCr 374.25Cr 366.58Cr 15TCr
Net income 3.26Cr 45.88L 39.56L 36.5L 34.83L 64.36L 41Cr 70.55L 4.34Cr 1.67Cr 19Cr 1.72Cr 1.69Cr 71Cr 52Cr 7.3Cr 6.29Cr 5.81Cr 5.54Cr 10Cr 646.55Cr 11Cr 69Cr 27Cr 308.79Cr 27Cr 27Cr 1.13TCr
Net Debt -268.72Cr -38Cr -33Cr -30Cr -29Cr -53Cr -3.35TCr -58Cr -357.66Cr -137.89Cr -1.6TCr -141.79Cr -138.89Cr -5.87TCr -247.58Cr -35Cr -30Cr -28Cr -26Cr -49Cr -3.09TCr -54Cr -329.52Cr -127.04Cr -1.47TCr -130.64Cr -127.96Cr -5.4TCr
More financial data * Estimated data
Logo Guangzhou Kingmed Diagnostics Group Co., Ltd.
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Employees
10,413
More about the company
Date Price Change Volume
17/25/17 30.18 ¥ -1.02% 39,16,006
14/25/14 30.49 ¥ +1.26% 68,86,308
13/25/13 30.11 ¥ -0.13% 33,59,914
12/25/12 30.15 ¥ +0.80% 45,97,114
11/25/11 29.91 ¥ -0.37% 25,01,214

End-of-day quote Shanghai S.E., November 17, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
30.18CNY
Average target price
30.82CNY
Spread / Average Target
+2.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603882 Stock
BLACK FRIDAY -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
d
:
:
BENEFIT NOW